Focal lesion in the splenium of the corpus callosum in epileptic patients: Antiepileptic drug toxicity?

American Journal of Neuroradiology

Volumn 20, Issue 1, 1999, Pages 125-129

  Kim, Sam Soo ^b   Chang, Kee Hyun ^a   Kim, Sung Tae ^b   Suh, Dae Chul ^b   Cheon, Jung Eun ^b   Jeong, Sang Wuk ^b   Han, Moon Hee ^b   Lee, Sang Kun ^b  

^a Seoul National University College of Medicine   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; PHENYTOIN; VIGABATRIN;

ADULT; ARTICLE; BRAIN EDEMA; BRAIN INJURY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORPUS CALLOSUM; DEMYELINATION; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SEIZURE;

ADULT; ANTICONVULSANTS; CORPUS CALLOSUM; EPILEPSY, COMPLEX PARTIAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PHENYTOIN; VIGABATRIN;

EID: 0342656605     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Chason DP, Fleckenstein JL, Ginsburg ML, Mendelsohn DB, Mathews D. Transient splenial edema in epilepsy: MR imaging evaluation. Presented at the annual meeting of the American Society of Neuroradiology: June 21-27, 1996; Seattle, WA
2. Georgy BA, Hesselink JR, Jernigan TL. MR imaging of the corpus callosum. AJR Am J Roentgenol 1993;160:949-955
3. Kieburtz KD, Ketonen L, Zettelmaier AE, Kido D, Caine ED, Simon JH. MRI findings in HIV cognitive impairment. Arch Neurol 1990;47:643-645
4. Chang KH, Cha SH, Han MH, Park SH, Nah DL, Hong JH. Marchiafava-Bignami disease: serial changes in corpus callosum on MRI. Neuroradiology 1992;34:480-482
5. Tobita M, MochUuki H, Takahashi S, Onoderma H, Itoyama Y, Iwasaki Y. A case of Marchiafava-Bignami disease with complete recovery: sequential imaging documenting improvement of callosal lesions. Tohoku J Exp Med 1997;182:175-179
6. Rumack CM, Guggenheim MA, Fasules JW, Burdick D. Transient positive computed tomographic scan. J Pediatr 1980;48: 866-869
7. Jamakumar PN, Taly AB, Mohan PK. Transient computerizes tomographic abnormalities following partial seizure. Acta Neurol Scand 1985;72:26-29
8. Kramer RE, Luders H, Lesser RP, et al. Transient focal abnormalities of neuroimaging studies during focal status epilepticus. Epilepsia 1987;28:528-532
9. Henry TR, Drury I, Brunberg JA, Pennel PB, McKeever PE, Beydoun A. Focal cerebral magnetic resonance changes associated with partial status epilepticus. Epilepsia 1994;35:35-41
10. Tien RD, Felsberg GJ. The hippocampus in status epilepticus: demonstration of signal intensity and morphologic changes with sequential fast spin-echo MR imaging. Radiology 1995; 194:249-256
11. Ziegler DK. Toxicity to the nervous system of diphenylhydantoin: a review. Int J Neurol 1978;11:383-400
12. Ramirez JA, Mendell JR, Warmolts JR, Griggs RC. Phenytoin neuropathy: structural changes in the sural nerve. Ann Neurol 1986;19:162-167
13. Graham DI, Lantos PL. Greenfield's Neuropathology. 6th ed. London: Arnold; 1997:624
14. Butler WH, Ford GP, Newberne JW. A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-Hooded rats. Toxicol Patlml 1987; 15:143-148
15. Graham D. Neuropathology of vigabatrin. Br J Clin Pharmacol 1989:27(Suppl 1):43S-45S
16. Gibson JP, Yarrington JT, Loudy DE, Gerbig CG, Hurst GH. Newberne JW. Chronic toxicity studies with vigabatrin, a GABA-transaminase inhibitor. Toxicol Pathol 1990;18:225-238
17. Weiss KL, Sehroeder CE, Kastin SJ, et al. MRI monitoring of vigabatrin-induced intramyelinic edema in dogs. Neurology 1994;44:1944-1949
18. Pederson B, Hojgaard K, Dam M. Vigabatrin: no microvacuolation in a human brain. Epilepsy Res 1987;1:74-76
19. Agosti R, Yasargil G, Egil M, et al. Neuropathology of a human hippocampus following long-term treatment with vigabatrin: lack of microvacuoles. Epilepsy Res 1990;6:166-170
20. Luders HN. Epilepsy Surgery. New York: Raven; 1992;353-354